Active Portfolio

We are proud to have one of the most extensive pharma services investment portfolios in the industry.

Pharma Services

Aetion’s mission is to power critical decisions in healthcare with data science-driven technology. The company delivers real-world evidence for life sciences companies, payers, at-risk providers, and regulators to assess the safety, effectiveness, and value of medications — what works best, for whom, and when.

Interim CEO: Jeremy Rassen
Investor: Tom Rodgers
Current Partner: Carrie Williams

Q

Aetion’s mission is to power critical decisions in healthcare with data science-driven technology. The company delivers real-world evidence for life sciences companies, payers, at-risk providers, and regulators to assess the safety, effectiveness, and value of medications — what works best, for whom, and when.

Interim CEO: Jeremy Rassen
Investor: Tom Rodgers
Current Partner: Carrie Williams

Q

Aledade partners with independent practices, health centers, and clinics to build and lead ACOs anchored in primary care. Aledade offers a comprehensive range of capabilities at scale, including cutting-edge data analytics, guided workflows, unparalleled regulatory expertise, strong payer relationships, and local support.

CEO: Farzad Mostashari
Investor: Dave Schult

Q

Aster Insights

Aster Insights, formerly known as M2GEN, is an oncology-focused health informatics solutions company that aggregates and analyzes clinical and molecular data to accelerate the discovery, development, and delivery of personalized therapies.

CEO: Jim Gabriele
Investor: Dave Schulte

Atropos Health works with health systems and life science companies to provide on-demand evidence from real world data to close evidence gaps. Atropos Health’s proprietary approach has proven to elevate clinical outcomes, accelerate research, and drive operational efficiency.

Investor: Michelle Snyder

Q

CancerIQ is a precision cancer detection and prevention platform that makes it easy for providers to gather patient data, map it to evidence-based guidelines, create personalized care plans, and integrate information across patients’ care teams.

CEO: Feyi Olopade Ayodele
Investor: Michelle Snyder

Q

Clinical ink is the global life science company that brings data, technology, and patient science together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drives the industry standard for data precision and ushers in a new generation of clinical trials.

CEO: Ed Seguine
Investor: Dave Schulte

Q

AllyAlign Health is the leading convener and owner of Medicare Advantage plans designed for senior housing residents. They connect facilities, providers, and home and community-based services through centralized care teams and a common care management platform — improving outcomes and lowering costs for post-acute and long-term care providers.

CEO: Will Saunders
Investor: Dave Schulte

Q

Evidation measures health in everyday life and enables anyone to participate in ground-breaking research and health programs. The company’s Achievement platform generates data with unprecedented speed and rigor and is trusted by leading organizations to better understand health and disease outside the clinic walls.

CEO: Deborah Kilpatrick, Christine Lemke
Investor: Carrie Williams

Q

Galileo is reimagining the care relationship between patients and doctors, pairing an exceptional clinical team with next-generation technology to empower the dialog that helps people live better, healthier lives. The company’s mission is to make healthcare more effective and affordable for all, including the underserved.

CEO: Tom Lee
Investor: Tom Leer

Q

Serving complex patients in the home with greater convenience, better outcomes, and higher satisfaction

CEO: Matthew Chance
Investor: Dave Schulte

Q

RxLightning logo tile

HIMS is on a mission to make it easier for people to access the prescriptions, products, and medical advice they need — especially about the things they find hard to talk about.

CEO: Andrew Dudum
Investor: Tom Rodgers

Q

Inbound Health provides the full stack of capabilities needed to enable care partners to launch and scale hospital and skilled nursing-at-home service lines.

CEO: Dave Kerwar
Investor: Michelle Snyder

Q

IVX Health is a rapidly growing provider of low-cost, consumer-centric infusion centers serving patients on expensive specialty biologics. Patients receive treatment in convenient locations, at convenient hours, and with private suites including all the comforts of home such as WiFi, media, leather recliners, and more.

CEO: Doug Ghertner
Investor: Dave Schulte

Q

Komodo combines the world’s most comprehensive view of patient encounters with innovative algorithms and clinical expertise to track the unique patient journeys over 300m+ individuals. They empower life science companies, payers, and providers to create a more cost-effective value-driven healthcare system.

CEO: Arif Nathoo
Investor: Dave Schulte

Q

Koneska is making clinical research more agile, safe, and friendly for participants. The company offers life science and research organizations end to end, patient centric digital biomarker solutions for remotely collected clinical data that support drug development and market strategy decision making.

CEO: Chris Benko
Investor: Carrie Williams

Q

Kyruus brings automation and organization to one of the most important transactions in healthcare — patient referrals. Kyruus automates the referral process and leverages machine learning and artificial intelligence to match the right care provider with the right patient, at the right time.

CEO: Graham Gardner
Investor: Tom Rodgers
Current Investor: Carrie Williams

Q

	Lambert Vet Supply is recognized as the professional’s authority in the pet care business. The company provides high-quality pet medications, pet supplies, and veterinary supplies at competitive prices.
Website	CEO: Douglas Lambert Investor: Carrie Williams

Q

	Lightship is the leader in enterprise level, direct-to-patient clinical research solutions. The company engages patients at home, making clinical research more accessible for everyone. Utilizing an integrated digital platform, patients can seamlessly engage with doctors, coordinators, and nurses at all phases of a clinical study.
Website	CEO: David MacMurchy Investor: Dave Schulte

Q

Matternet is the developer of the world’s leading technology platform for on-demand aerial delivery in urban environments. The company provides its technology platform as a service to healthcare, e-commerce, and logistics organizations throughout the world.

CEO: Andreas Raptopoulos
Investor: Tom Rodgers
Current Partner: Jennifer Carter

Q

Reimagine Care provides value based, oncology care at home on behalf of health systems and community oncology practices. The company creates a better experience for patients and generates savings through identifying individuals who will benefit from home care and managing and coordinating care delivery.

CEO: Aaron Gerber
Investor: Michelle Snyder

Q

Mural makes it easy for trial participants to get reimbursed, get to the site, and stay connected with their care team.

CEO: Sam Whitaker
Investor: Carrie Williams

Q

Our vision is to transform the specialty prescription enrollment process so that it’s never a barrier to life-altering therapies. We do this by leveraging a first of its kind collaborative and innovative platform that fits both the patients’ and the providers’ needs.

CEO: Julia Regan
Investor: Carrie Williams

Q

RxVantage connects healthcare providers and their staff with the right life science experts to get the information they need, when they need it most.

CEO: Dan Gilman
Investor: Michelle Snyder

Q

Saama provides a unified approach to clinical trial data management and analytics on behalf of life science companies. The company’s AI driven applications have the ability to learn complex patterns among clinical data and provide insights to accelerate clinical research across a variety of domains and therapeutic areas.

CEO: Suresh Katta
Investor: Dave Schulte

Q

Truveris brings transparency to the prescription drug ecosystem through data driven innovations. The company’s platform offers customers — including employers, retailers, pharmacy benefits stakeholders and manufacturers — the data and insights they need to manage rising costs and market access challenges.

CEO: Nanette Oddo
Investor: Tom Rodgers

Q

Health-Tech Services

Galileo tile

Xealth is a digital health prescribing platform that enables clinicians to easily integrate, prescribe, and monitor digital health tools for patients from their EHR workflows, including: patient education, third-party apps and programs, device monitoring, and non-clinical services such as ride shares, food delivery, and more.

CEO: Mike McSherry
Investor: Carrie Williams

Q

Select Alumni Investments

Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Using a blend of cloud-based technologies, specialized support, and integrated data and programs, Accolade navigates people through the healthcare system with trust, empathy, and ease.

Investor: Tom Rodgers

Q

Amwell connects and enables providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. The company’s single, comprehensive platform supports all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living.

CEO: Roy Schoenberg
Investor: Tom Rodgers
Current Partner: Jennifer Carter

Q

ClearCare Online is a cloud-based home care software platform supporting private-duty home care companies for efficient, cost-effective aging at home. ClearCare helps home care agencies grow, operate efficiently, and improve the quality and documentation of care on behalf of their patients.

Investor: Tom Rodgers

Q

Evariant is a healthcare CRM platform for health systems delivering precise, efficient care solutions both inside and outside the organization’s walls. The solution is based on a centralized healthcare data hub and analytics and communication engine capable of identifying, executing, and measuring all types of engagement initiatives.

Investor: Tom Rodgers

Q

GRAIL’s mission is to detect cancer early, when it can be cured. The company’s pioneering technology to detect and identify multiple deadly cancer types early uses next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science.

CEO: Hans Bishop
Investor: Tom Rodgers
Current Partner: Dave Schulte

Q

Landmark’s physician-led multidisciplinary teams, specializing in complex chronic care, work with patients’ existing healthcare networks to bring medical, behavioral, and palliative care, along with social services, to individuals where they reside.

Investor: Dave Schulte

Q

OncoHealth is a digital health company that combines real-world data and cutting-edge analytics to deliver solutions used by payors, employers, providers, life science companies and patients for navigating the physical, mental and financial complexities of cancer. OncoHealth offers digital solutions for treatment review, real-world evidence, and virtual care across all cancer types.

CEO: Rick Dean
Investor: Dave Schulte

Q

Propeller Health is a leading digital health company dedicated to making life better for every person with chronic respiratory disease. Propeller creates products to improve clinical outcomes for patients through connectivity, analytics, and companion digital experiences.

Investor: Carrie Williams

Q

SHYFT Analytics is the leader in cloud-based solutions for global life sciences organizations. The company delivers smarter, timelier access to novel insights that provide new ways to increase competitiveness, enhance customer engagement, grow revenue, and improve patient health.

Investor: Dave Schulte

Q

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the leader in whole-person virtual care, Teladoc uses proprietary health signals and personalized interactions to drive better health outcomes at every stage in a person’s health journey.

Q